Compound Index
IGF-18Hexarelin5Selank4GHRP-24NMN / NR / NAD+ Precursors4BPC-1573TB-5003Ipamorelin3CJC-1295 (DAC)3CJC-1295 / Ipamorelin3CJC-1295 No DAC3Sermorelin3MK-6773Semaglutide3Tirzepatide3Retatrutide3AOD-96043GHK-Cu3Epitalon3Semax3NAD+3PT-1413Melanotan II3Thymosin Alpha-13LL-373MOTS-c3SS-31 (Elamipretide)3Tesamorelin3DSIP3Kisspeptin3
GH Axis10 min read
GHRP-2: The Potent Growth Hormone Releasing Peptide Research Guide
A comprehensive research guide to GHRP-2: GHSR-1a pharmacology, Arvat 1997 dose-response data, cortisol/ACTH co-stimulation profile, CJC-1295 No DAC synergy, tachyphylaxis mechanisms, and full preclinical protocol design for GH axis research.
June 1, 2026Read
GH Axis12 min read
CJC-1295 and Ipamorelin: The Complete Combination Research Guide
A comprehensive mechanistic and protocol guide for CJC-1295 No DAC + ipamorelin combination research: orthogonal receptor pharmacology, 8–12× synergistic GH amplification, published dosing data, IGF-1 endpoints, and full study design.
June 1, 2026Read
Research Fundamentals12 min read
Peptide Bioavailability by Route of Administration: SC vs IP vs IN vs Oral — The Definitive Research Guide
A comprehensive reference covering subcutaneous, intraperitoneal, intranasal, intravenous, and oral peptide delivery routes — pharmacokinetics, bioavailability data, practical protocols, and study design implications for each compound class.
June 1, 2026Read